Swine influenza virus vaccine serologic cross-reactivity to contemporary US swine H3N2 and efficacy in pigs infected with an H3N2 similar to 2011–2012 H3N2v
Version of Record online: 14 NOV 2013
Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
Influenza and Other Respiratory Viruses
Special Issue: Proceedings of the 2nd International Symposium on Neglected Influenza Viruses, Dublin, Ireland, 7-8 March 2013. Edited by: Thomas Chambers and Ariel Pereda. Publication of this supplement was supported by isirv.
Volume 7, Issue Supplement s4, pages 32–41, December 2013
How to Cite
2013) Swine influenza virus vaccine serologic cross-reactivity to contemporary US swine H3N2 and efficacy in pigs infected with an H3N2 similar to 2011–2012 H3N2v. Influenza and Other Respiratory Viruses 7(Suppl. 4), 32–41.et al. (
- Issue online: 14 NOV 2013
- Version of Record online: 14 NOV 2013
Table S1. Percent nucleotide identity of the hemagglutinin (HA) gene compared between H3N2 isolates used in the animal trials.
Figure S1. Phylogeny of representative and study H3N2 influenza A isolates using the hemagglutinin (HA) gene.
Figure S2. Average rectal temperature of nonvaccinated, challenged pigs (C), MDA+ -nonvaccinated, challenged pigs (MDA/C), MDA+ -vaccinated, challenged pigs (MDA/V/C), and MDA− -vaccinated, challenged pigs (V/C) before infection (0 days post infection; dpi) and after infection (1–5 dpi) with NY11 (H3N2v-like virus) at 7 weeks of age. Results of nonchallenged pigs are not included.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.